HUP0102025A3 - Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use - Google Patents

Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use

Info

Publication number
HUP0102025A3
HUP0102025A3 HU0102025A HUP0102025A HUP0102025A3 HU P0102025 A3 HUP0102025 A3 HU P0102025A3 HU 0102025 A HU0102025 A HU 0102025A HU P0102025 A HUP0102025 A HU P0102025A HU P0102025 A3 HUP0102025 A3 HU P0102025A3
Authority
HU
Hungary
Prior art keywords
oxadiazolone
derivatives
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
HU0102025A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of HUP0102025A2 publication Critical patent/HUP0102025A2/hu
Publication of HUP0102025A3 publication Critical patent/HUP0102025A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/101,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/1131,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU0102025A 1998-01-29 1999-01-15 Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use HUP0102025A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7296698P 1998-01-29 1998-01-29
US10227498P 1998-09-29 1998-09-29
PCT/US1999/000910 WO1999038510A1 (en) 1998-01-29 1999-01-15 Derivatives of 1,3,4-oxadiazolone

Publications (2)

Publication Number Publication Date
HUP0102025A2 HUP0102025A2 (hu) 2001-11-28
HUP0102025A3 true HUP0102025A3 (en) 2002-01-28

Family

ID=26753969

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102025A HUP0102025A3 (en) 1998-01-29 1999-01-15 Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use

Country Status (27)

Country Link
US (1) US6034113A (hu)
EP (1) EP1051173A4 (hu)
JP (1) JP2002527352A (hu)
KR (1) KR20010077838A (hu)
CN (1) CN1150175C (hu)
AR (1) AR010712A1 (hu)
AU (1) AU735704B2 (hu)
BG (1) BG104706A (hu)
BR (1) BR9913010A (hu)
CA (1) CA2318830A1 (hu)
CO (1) CO5090837A1 (hu)
EE (1) EE04089B1 (hu)
GE (1) GEP20032914B (hu)
HU (1) HUP0102025A3 (hu)
ID (1) ID26909A (hu)
IL (1) IL137518A0 (hu)
LT (1) LT4838B (hu)
LV (1) LV12559B (hu)
NO (1) NO317102B1 (hu)
NZ (1) NZ505409A (hu)
PL (1) PL342060A1 (hu)
RU (1) RU2202548C2 (hu)
SK (1) SK10852000A3 (hu)
TR (1) TR200002019T2 (hu)
TW (1) TW550075B (hu)
UA (1) UA58579C2 (hu)
WO (1) WO1999038510A1 (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038853A1 (en) * 1998-01-29 1999-08-05 Bristol-Myers Squibb Company Amino acid derivatives of daryl 1,3,4-oxadiazolone
US6297241B1 (en) 1999-01-29 2001-10-02 Bristol-Myers Squibb Company Carbamate derivatives of diaryl 1,3,4-oxadiazolone
ID29269A (id) * 1999-01-29 2001-08-16 Bristol Myers Squibb Co Turunan-turunan karbamat dari diaril 1,3,4,oksadiazolon
US6326388B1 (en) * 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
WO2002072088A2 (en) 2001-02-20 2002-09-19 Bristol-Myers Squibb Company Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases
BR0208956A (pt) * 2001-04-16 2004-07-13 Tanabe Seiyaku Co Abridor de canais de k ativados por cálcio de grande condutância
US6909027B1 (en) * 2001-08-13 2005-06-21 Perry Robins Method of forming an in-situ film dressing and the composition of the film-forming material
US7119246B2 (en) * 2002-06-25 2006-10-10 Perry Robins Method of treating acne
AU2013262320B2 (en) 2012-05-16 2018-02-22 Techfields Pharma Co., Ltd. High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
JP5855599B2 (ja) * 2013-04-30 2016-02-09 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
CN104710379B (zh) * 2015-03-09 2017-01-18 华南理工大学 一种bms‑191011的合成方法
JP6165816B2 (ja) * 2015-10-01 2017-07-19 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ
JP2020508328A (ja) * 2017-02-24 2020-03-19 オービッド・セラピューティクス・インコーポレイテッドOvid Therapeutics Inc. 発作性障害の治療方法
CN110987847B (zh) * 2019-12-11 2021-02-19 苏州今蓝纳米科技有限公司 1,3,4-噁二唑衍生物在检测酸以及数据加密和储存中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH583213A5 (hu) * 1973-05-21 1976-12-31 Ciba Geigy Ag
IT1251488B (it) * 1991-09-17 1995-05-15 Mini Ricerca Scient Tecnolog Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
WO1999038853A1 (en) * 1998-01-29 1999-08-05 Bristol-Myers Squibb Company Amino acid derivatives of daryl 1,3,4-oxadiazolone

Also Published As

Publication number Publication date
GEP20032914B (en) 2003-03-25
JP2002527352A (ja) 2002-08-27
EE200000447A (et) 2001-12-17
EP1051173A1 (en) 2000-11-15
BG104706A (en) 2001-04-30
TR200002019T2 (tr) 2000-11-21
LV12559B (en) 2001-04-20
CO5090837A1 (es) 2001-10-30
LT4838B (lt) 2001-08-27
SK10852000A3 (sk) 2002-02-05
AU735704B2 (en) 2001-07-12
BR9913010A (pt) 2001-05-08
AR010712A1 (es) 2000-07-12
US6034113A (en) 2000-03-07
CN1150175C (zh) 2004-05-19
HUP0102025A2 (hu) 2001-11-28
AU2230899A (en) 1999-08-16
UA58579C2 (uk) 2003-08-15
NO20003825L (no) 2000-07-26
ID26909A (id) 2001-02-15
LT2000068A (en) 2001-03-26
EP1051173A4 (en) 2002-07-31
WO1999038510A1 (en) 1999-08-05
EE04089B1 (et) 2003-08-15
TW550075B (en) 2003-09-01
LV12559A (en) 2000-11-20
RU2202548C2 (ru) 2003-04-20
CN1289249A (zh) 2001-03-28
NO317102B1 (no) 2004-08-09
NZ505409A (en) 2003-08-29
CA2318830A1 (en) 1999-08-05
PL342060A1 (en) 2001-05-21
KR20010077838A (ko) 2001-08-20
NO20003825D0 (no) 2000-07-26
IL137518A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
HUS1200028I1 (hu) 4"-Szubsztituált-9-dezoxo-9a-aza-9a-homoeritromicin-származékok és ezeket tartalmazó gyógyszerek
HUP9700709A3 (en) 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
IL140862A0 (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
IL123648A0 (en) 1,4-Benzothiazepine-1,1-dioxides their preparation and pharmaceutical compositions containing them
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
HUP9900413A3 (en) Use of coralyne derivatives, new coralyne derivatives and use thereof, pharmaceutical compositions containing these new coralyne derivatives
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
HUP0200588A2 (hu) Diarilszármazékok és azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
SI0918059T1 (en) Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
HUP9904694A3 (en) Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them
HUP0105075A3 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them
HUP0101960A3 (en) Metabolites of ecteinascidin 743, their use and pharmaceutical compositions containing them
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
HUP9800147A3 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them